Compare $AIM vs $LIANY | Chartloom

Compare

$AIM vs $LIANY

AIM ImmunoTech Inc · LianBio

AIM

AIM ImmunoTech Inc

LIANY

LianBio

Compare $AIM vs $LIANY

Comparing AIM ImmunoTech Inc and LianBio

AIMAIM ImmunoTech Inc

LIANYLianBio

AIMAIM ImmunoTech Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-21.5%

YTD performance

-84.4%

52W performance

-92.8%

FCF yield

-292.9%

LIANYLianBio

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-36.4%

52W performance

-69.8%

FCF yield

-1287.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AIM

LIANY

Detailed metrics comparison

AIM

AIM ImmunoTech Inc

LIANY

LianBio

Market Cap

AIM$5M

LIANY$7M

Enterprise Value

AIM$-1M

LIANY$-97M

Price

AIM$0.18

LIANY$0.06

P/E Ratio

AIMN/A

LIANYN/A

P/S Ratio

AIM52.52x

LIANY0.00x

EV/Sales

AIM-13.57x

LIANY0.00x

EV/EBITDA

AIM0.00x

LIANY0.00x

P/B Ratio

AIM0.91x

LIANY0.03x

P/FCF Ratio

AIMN/A

LIANYN/A

EV/FCF

AIM0.09x

LIANY1.15x

PEG Ratio

AIMN/A

LIANYN/A

Forward P/E (NTM)

AIMN/A

LIANYN/A

Forward P/S (NTM)

AIMN/A

LIANYN/A

Revenue (TTM)

AIM$95K

LIANY$0

Revenue Growth (YoY)

AIM-21.5%

LIANYN/A

Forward Rev Growth

AIM-32.4%

LIANY0.0%

Gross Margin (TTM)

AIM-23.2%

LIANY0.0%

Operating Margin (TTM)

AIM0.0%

LIANY0.0%

EBITDA Margin (TTM)

AIM-10985.3%

LIANY0.0%

Net Margin (TTM)

AIM-15021.1%

LIANY0.0%

FCF Margin (TTM)

AIM-15385.3%

LIANYN/A

Net Income (TTM)

AIM$-14M

LIANY$-88M

FCF (TTM)

AIM$-15M

LIANY$-84M

EPS (TTM)

AIM-$0.83

LIANY-$0.82

ROE (TTM)

AIM-13803.0%

LIANY-3807.0%

ROA (TTM)

AIM-17514.0%

LIANY-3023.0%

ROIC (TTM)

AIM-7694.0%

LIANY-3807.0%

Cash

AIM$10M

LIANY$104M

Debt

AIM$4M

LIANY$0

Net Cash/Debt

AIM$6M

LIANY$104M

Current Ratio (TTM)

AIM2.11x

LIANY10.07x

Quick Ratio (TTM)

AIM2.01x

LIANY9.92x

Debt/Equity (TTM)

AIM0.47x

LIANY0.00x

Debt/Assets (TTM)

AIM0.0%

LIANY0.0%

Interest Coverage (TTM)

AIMN/A

LIANYN/A

Net Debt/EBITDA (TTM)

AIM0.00x

LIANY0.00x

Beta

AIM1.35

LIANY0.16

52W Performance

AIM-92.8%

LIANY-69.8%

YTD Performance

AIM-84.4%

LIANY-36.4%

% from 52W High

AIM-93.6%

LIANY-86.3%

% from 52W Low

AIM8.4%

LIANY186.3%

Asset Turnover (TTM)

AIM0.01x

LIANY0.00x

FCF Yield (TTM)

AIM-292.9%

LIANY-1287.0%

Earnings Yield (TTM)

AIM-286.0%

LIANY-1348.1%

Dividend Yield (TTM)

AIMN/A

LIANYN/A

Rule of 40

AIM-15,406.8

LIANY0.0

EV/GP/RG

AIMN/A

LIANYN/A

Ticker research

View AIM research View LIANY research

Metric	AIM AIM ImmunoTech Inc	LIANY LianBio
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-1M	$-97M
Price	$0.18	$0.06
P/E Ratio	N/A	N/A
P/S Ratio	52.52x	0.00x
EV/Sales	-13.57x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.91x	0.03x
P/FCF Ratio	N/A	N/A
EV/FCF	0.09x	1.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$95K	$0
Revenue Growth (YoY)	-21.5%	N/A
Forward Rev Growth	-32.4%	0.0%
Profitability
Gross Margin (TTM)	-23.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-10985.3%	0.0%
Net Margin (TTM)	-15021.1%	0.0%
FCF Margin (TTM)	-15385.3%	N/A
Net Income (TTM)	$-14M	$-88M
FCF (TTM)	$-15M	$-84M
EPS (TTM)	-$0.83	-$0.82
ROE (TTM)	-13803.0%	-3807.0%
ROA (TTM)	-17514.0%	-3023.0%
ROIC (TTM)	-7694.0%	-3807.0%
Financial Health
Cash	$10M	$104M
Debt	$4M	$0
Net Cash/Debt	$6M	$104M
Current Ratio (TTM)	2.11x	10.07x
Quick Ratio (TTM)	2.01x	9.92x
Debt/Equity (TTM)	0.47x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.35	0.16
52W Performance	-92.8%	-69.8%
YTD Performance	-84.4%	-36.4%
% from 52W High	-93.6%	-86.3%
% from 52W Low	8.4%	186.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-292.9%	-1287.0%
Earnings Yield (TTM)	-286.0%	-1348.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-15,406.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AIM research	View LIANY research

Valuation

P/S Ratio

LIANY

0.00x

AIM

52.52x

EV/FCF

AIM

0.09x

LIANY

1.15x

Growth & revenue

Revenue Growth TTM

AIM

-21.5%

Forward Revenue Growth

LIANY

0.0%

AIM

-32.4%

Profitability & performance

Gross Margin

LIANY

0.0%

AIM

-23.2%

ROE

LIANY

-3807.0%

AIM

-13803.0%

FCF Yield %

AIM

-292.9%

LIANY

-1287.0%

52-Week Performance

LIANY

-69.8%

AIM

-92.8%

Detailed metrics comparison

AIM

AIM ImmunoTech Inc

LIANY

LianBio

Market Cap

AIM$5M

LIANY$7M

Enterprise Value

AIM$-1M

LIANY$-97M

Price

AIM$0.18

LIANY$0.06

P/E Ratio

AIMN/A

LIANYN/A

P/S Ratio

AIM52.52x

LIANY0.00x

EV/Sales

AIM-13.57x

LIANY0.00x

EV/EBITDA

AIM0.00x

LIANY0.00x

P/B Ratio

AIM0.91x

LIANY0.03x

P/FCF Ratio

AIMN/A

LIANYN/A

EV/FCF

AIM0.09x

LIANY1.15x

PEG Ratio

AIMN/A

LIANYN/A

Forward P/E (NTM)

AIMN/A

LIANYN/A

Forward P/S (NTM)

AIMN/A

LIANYN/A

Revenue (TTM)

AIM$95K

LIANY$0

Revenue Growth (YoY)

AIM-21.5%

LIANYN/A

Forward Rev Growth

AIM-32.4%

LIANY0.0%

Gross Margin (TTM)

AIM-23.2%

LIANY0.0%

Operating Margin (TTM)

AIM0.0%

LIANY0.0%

EBITDA Margin (TTM)

AIM-10985.3%

LIANY0.0%

Net Margin (TTM)

AIM-15021.1%

LIANY0.0%

FCF Margin (TTM)

AIM-15385.3%

LIANYN/A

Net Income (TTM)

AIM$-14M

LIANY$-88M

FCF (TTM)

AIM$-15M

LIANY$-84M

EPS (TTM)

AIM-$0.83

LIANY-$0.82

ROE (TTM)

AIM-13803.0%

LIANY-3807.0%

ROA (TTM)

AIM-17514.0%

LIANY-3023.0%

ROIC (TTM)

AIM-7694.0%

LIANY-3807.0%

Cash

AIM$10M

LIANY$104M

Debt

AIM$4M

LIANY$0

Net Cash/Debt

AIM$6M

LIANY$104M

Current Ratio (TTM)

AIM2.11x

LIANY10.07x

Quick Ratio (TTM)

AIM2.01x

LIANY9.92x

Debt/Equity (TTM)

AIM0.47x

LIANY0.00x

Debt/Assets (TTM)

AIM0.0%

LIANY0.0%

Interest Coverage (TTM)

AIMN/A

LIANYN/A

Net Debt/EBITDA (TTM)

AIM0.00x

LIANY0.00x

Beta

AIM1.35

LIANY0.16

52W Performance

AIM-92.8%

LIANY-69.8%

YTD Performance

AIM-84.4%

LIANY-36.4%

% from 52W High

AIM-93.6%

LIANY-86.3%

% from 52W Low

AIM8.4%

LIANY186.3%

Asset Turnover (TTM)

AIM0.01x

LIANY0.00x

FCF Yield (TTM)

AIM-292.9%

LIANY-1287.0%

Earnings Yield (TTM)

AIM-286.0%

LIANY-1348.1%

Dividend Yield (TTM)

AIMN/A

LIANYN/A

Rule of 40

AIM-15,406.8

LIANY0.0

EV/GP/RG

AIMN/A

LIANYN/A

Ticker research

View AIM research View LIANY research

Metric	AIM AIM ImmunoTech Inc	LIANY LianBio
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-1M	$-97M
Price	$0.18	$0.06
P/E Ratio	N/A	N/A
P/S Ratio	52.52x	0.00x
EV/Sales	-13.57x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.91x	0.03x
P/FCF Ratio	N/A	N/A
EV/FCF	0.09x	1.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$95K	$0
Revenue Growth (YoY)	-21.5%	N/A
Forward Rev Growth	-32.4%	0.0%
Profitability
Gross Margin (TTM)	-23.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-10985.3%	0.0%
Net Margin (TTM)	-15021.1%	0.0%
FCF Margin (TTM)	-15385.3%	N/A
Net Income (TTM)	$-14M	$-88M
FCF (TTM)	$-15M	$-84M
EPS (TTM)	-$0.83	-$0.82
ROE (TTM)	-13803.0%	-3807.0%
ROA (TTM)	-17514.0%	-3023.0%
ROIC (TTM)	-7694.0%	-3807.0%
Financial Health
Cash	$10M	$104M
Debt	$4M	$0
Net Cash/Debt	$6M	$104M
Current Ratio (TTM)	2.11x	10.07x
Quick Ratio (TTM)	2.01x	9.92x
Debt/Equity (TTM)	0.47x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.35	0.16
52W Performance	-92.8%	-69.8%
YTD Performance	-84.4%	-36.4%
% from 52W High	-93.6%	-86.3%
% from 52W Low	8.4%	186.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-292.9%	-1287.0%
Earnings Yield (TTM)	-286.0%	-1348.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-15,406.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AIM research	View LIANY research